Combination therapy of ZD6474 with 5-FU or/and CPT-11

Details for Australian Patent Application No. 2004212255 (hide)

Owner AstraZeneca AB

Inventors Ryan, Anderson Joseph; Wedge Stephen Robert

Agent Davies Collison Cave

Pub. Number AU-B-2004212255

PCT Pub. Number WO2004/071397

Priority 0318311.8 05.08.03 GB; 0314100.9 18.06.03 GB; 0303289.3 13.02.03 GB; 0316184.1 10.07.03 GB

Filing date 11 February 2004

Wipo publication date 26 August 2004

Acceptance publication date 5 July 2007

International Classifications

A61K 31/4745 (2006.01)

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

18 August 2005 PCT application entered the National Phase

  PCT publication WO2004/071397 Priority application(s): WO2004/071397

5 July 2007 Application Accepted

  Published as AU-B-2004212255

1 November 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004212258-Method of assaying for high performance mammals

2004212250-Skin composition